LNC
TMO icon

Lincoln National Corp’s Thermo Fisher Scientific TMO Stock Holding History

Lincoln National Corp’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,810
Closed -$4.54M – 1035
2024
Q1 		$4.54M Buy
7,810
+496
+7% +$278K 0.07% 170
2023
Q4 		$3.88M Buy
7,314
+512
+8% +$248K 0.07% 180
2023
Q3 		$3.44M Sell
6,802
-9
-0.1% -$4.8K 0.07% 165
2023
Q2 		$3.55M Buy
6,811
+67
+1% +$36.2K 0.07% 171
2023
Q1 		$3.89M Sell
6,744
-171
-2% -$96.4K 0.08% 145
2022
Q4 		$3.81M Buy
6,915
+1,050
+18% +$556K 0.09% 138
2022
Q3 		$2.97M Buy
5,865
+403
+7% +$226K 0.07% 151
2022
Q2 		$2.97M Buy
5,462
+56
+1% +$30.8K 0.07% 147
2022
Q1 		$3.19M Buy
5,406
+372
+7% +$214K 0.07% 153
2021
Q4 		$3.36M Buy
5,034
+163
+3% +$102K 0.07% 149
2021
Q3 		$2.78M Buy
4,871
+73
+2% +$40.1K 0.06% 165
2021
Q2 		$2.42M Buy
4,798
+189
+4% +$89.2K 0.05% 182
2021
Q1 		$2.1M Buy
4,609
+356
+8% +$170K 0.05% 185
2020
Q4 		$1.98M Buy
4,253
+267
+7% +$125K 0.05% 182
2020
Q3 		$1.76M Buy
3,986
+834
+26% +$345K 0.05% 178
2020
Q2 		$1.14M Buy
3,152
+296
+10% +$99.2K 0.04% 221
2020
Q1 		$810K Buy
2,856
+1,954
+217% +$616K 0.03% 246
2019
Q4 		$293K Sell
902
-17
-2% -$5.16K 0.01% 503
2019
Q3 		$267K Buy
919
+9
+1% +$2.58K 0.01% 472
2019
Q2 		$267K Buy
910
+145
+19% +$39.9K 0.01% 447
2019
Q1 		$209K Buy
+765
New +$190K 0.01% 472
2018
Q2 		– Sell
-2,711
Closed -$560K – 528
2018
Q1 		$560K Buy
+2,711
New +$569K 0.02% 251
2017
Q1 		– Sell
-1,919
Closed -$271K – 361
2016
Q4 		$271K Buy
1,919
+14
+0.7% +$2.06K 0.01% 243
2016
Q3 		$303K Buy
1,905
+71
+4% +$10.9K 0.02% 218
2016
Q2 		$271K Sell
1,834
-3,197
-64% -$472K 0.02% 223
2016
Q1 		$712K Buy
+5,031
New +$674K 0.05% 128

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lincoln National Corp's TMO Position: Q2 2024 in Review

Lincoln National Corp sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 7,810 shares — an estimated $4.54M sold.

Lincoln National Corp first reported a position in TMO in Q1 2016 and held it in 26 quarters. The position peaked at $4.54M in Q1 2024. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Lincoln National Corp reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 7,810 Thermo Fisher Scientific shares in Q2 2024, an estimated $4.54M.
  • Lincoln National Corp first reported a position in Thermo Fisher Scientific in Q1 2016 and held it in 26 quarters.
  • Lincoln National Corp's Thermo Fisher Scientific position peaked at $4.54M in Q1 2024.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.